Author: Kaloyan Staykov In mid-August, the government published for public discussion warmed-up proposals for reform of the drug policy, with the focus on improving access to medicinal products in the country. The problem with access arises mainly for two reasons: parallel export[1] – it is envisaged to create a restrictive list of medicines whose export can be …
More »
EKIP– Expert Club for Economics and Politics A Different Opinion